[Evaluation of the pharmacological properties of a new steroid curarelike agent, RGH 1106].
Tests on cats showed the compound RGH 1106 to possess an antidepolarizing mechanism of action. The sequence of myorelaxation, arising under the effect of this agent, is characterized by relaxation in the first place of the musculus masseter, muscles of limbs, then of abdominal muscles and those of the diaphragm and, finally, of the intercostal muscles. RGH 1106 doses not possess cardiotropic m-cholinolytic action, does not exert a ganglion blocking effect, nor affects the central nervous system. It neither changes the blood supply of the myocardium and the uptake of oxygen by the latter, nor inhibits the acetylcholinesterase.
D000818:Animals; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004576:Electromyography; D005071:Evoked Potentials / Q000187:drug effects; D009126:Muscle Relaxation / Q000187:drug effects; D009132:Muscles / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D010197:Pancuronium / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects; D013569:Synapses / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects
D003473:Neuromuscular Nondepolarizing Agents; D011950:Receptors, Cholinergic; D010197:Pancuronium
Otsenka nekotorykh farmakologicheskikh svoĭstv novogo steroidnogo kurarepodobnogo sredstva RGH 1106.